ARA-290 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Lyophilized (freeze-dried) ARA-290 should be stored at -20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2-8°C (refrigerated) and use within 4-6 weeks. Never freeze reconstituted peptides.
How Do You Store ARA-290?
Proper storage is critical for maintaining ARA-290's potency and safety. As a Innate repair receptor agonist, anti-inflammatory peptide, ARA-290 is sensitive to heat, light, and moisture — improper storage can render it ineffective or harmful.
How Do You Store Lyophilized ARA-290?
Unreconstituted (freeze-dried) ARA-290: Store at -20°C (standard freezer) for maximum shelf life of 12-24+ months. Keep the vial sealed and away from moisture.
Room temperature storage is acceptable for short periods (shipping) but degrades potency over weeks. Refrigerator (2-8°C) storage extends this to several months.
How Do You Store Reconstituted ARA-290?
After mixing with bacteriostatic water: Store at 2-8°C (standard refrigerator). Use within 4-6 weeks for optimal potency.
Never freeze reconstituted ARA-290. Freezing and thawing damages the peptide structure. The bacteriostatic water's benzyl alcohol preservative is what allows the 4-6 week window — sterile water would give you only days.
Keep the vial upright and away from the refrigerator door (temperature fluctuations from opening/closing).
How Do You Know if ARA-290 Has Gone Bad?
Reconstituted ARA-290 should be clear and colorless. If you see cloudiness, particles, or discoloration — discard it. These indicate bacterial contamination or peptide degradation.
If stored properly, degradation is gradual and may not be visually apparent. This is why the 4-6 week window for reconstituted peptides exists.
Can You Travel With ARA-290?
Lyophilized ARA-290 can be shipped with cold packs and insulation. For short trips, a small cooler bag with an ice pack maintains adequate temperature.
Reconstituted ARA-290 is more temperature-sensitive and should be kept refrigerated during travel if possible.
Bottom Line on ARA-290 Storage
Freeze-dried: -20°C, sealed, 12+ months. Reconstituted: 2-8°C, use within 4-6 weeks, never freeze. Source from vendors who ship with proper cold-chain packaging.
Complete Guide
ARA-290 : Benefits, Dosage, Side Effects & Research
Related Reading
- ARA-290 Dosage Guide
- ARA-290 Benefits
- ARA-290 Side Effects
- ARA-290 Stacking Guide
- ARA-290 Cycle Guide
- ARA-290 Research
Calculate Your ARA-290 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for ARA-290.
Open Calculator →Research-Grade Sourcing
If you're going to research ARA-290, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is ARA-290?
ARA-290 (Erythropoietin-derived tissue-protective peptide) is a Innate repair receptor agonist, anti-inflammatory peptide. Synthetic 11-amino acid peptide engineered from the tissue-protective domain of erythropoietin (EPO). It is researched for neuropathic pain relief, inflammation reduction, nerve fiber regeneration, improved autonomic function, metabolic control in diabetes.
What is the recommended ARA-290 dosage?
Common dosages: 2-4 mg daily administered once daily via subcutaneous injection. Cycle length: 28 days typical; 8-16 weeks for extended response. Half-life: approximately 24 hours. Use our peptide calculator for exact reconstitution math.
What are the side effects of ARA-290?
Safe profile in multiple clinical trials. Minimal reported adverse events. Occasional mild injection site reactions. No serious safety concerns identified across diabetes, sarcoidosis, and neuropathy patient populations.
Is ARA-290 safe?
ARA-290 has shown a preliminary safety profile in research. Investigational. Underwent Phase II clinical trials. Not FDA-approved. All research should follow appropriate safety protocols.